Advertisements

Peter Reynolds

The life and times of Peter Reynolds

Archive for the ‘Business’ Category

Centre for Medicinal Cannabis CBD Report Confirmed as Cheap Marketing Stunt

leave a comment »

Steve Moore, ex-advisor to David Cameron, now leads the Centre for Medicinal Cannabis

At the end of June, the ‘Centre for Medicinal Cannabis’ (CMC) published a report which painted an appalling picture of the CBD market in the UK and has led to headlines and alarm everywhere that consumers are being ripped off and the whole industry is not to be trusted. See: Mischievous ‘Centre for Medicinal Cannabis’ Report Smears UK CBD Industry With Misleading Data

Now, as it publishes what it calls a “further update”, it is confirmed that the report and the extremely expensive PR operation around it is nothing more than a cheap marketing stunt.

The report claimed to have tested 30 major UK CBD products that can be purchased from the UK high street or bought online. It presented alarming results showing that many of the products contained far less CBD than claimed and almost half contained illegal levels of THC and/or CBN. It refused to release information about which products were concerned with evasive answers and excuses that there were ‘legal implications’. Now, in its further update, surprise, surprise, it says that all its members’ products were within 10% of the CBD content indicated on the label.

As CLEAR reported at the time, the report is nothing but a market manipulation exercise. We didn’t expect their preference for their own products to come so quickly and so brazenly, which is why we now christen the whole exercise a cheap stunt. Certainly, there are some rogue businesses and fake products but the impression given by this report is false, misleading and wildly inaccurate. Consumers can be confident if they buy from members of the two trade associations Cannabis Professionals (CannaPro) or Cannabis Trades Association (CTA) they will be getting a quality product which is lab tested and contains exactly what is claimed.

CMC now defines itself as a trade body, although it only has two or three members in the CBD business in the UK, which were formerly members of the long-established trade associations. It should be noted that the so-called ‘independent’ laboratory it used for testing CBD products is itself a member of CMC.

Advertisements

Written by Peter Reynolds

July 18, 2019 at 1:09 pm

Mischievous ‘Centre for Medicinal Cannabis’ Report Smears UK CBD Industry With Misleading Data

leave a comment »

A new report from the Centre for Medicinal Cannabis (CMC) paints an appalling picture of the CBD market in the UK and has led to headlines and alarm everywhere that consumers are being ripped off and the whole industry is not to be trusted.

Cannabis has great medical potential. But don’t fall for the CBD scam – The Guardian

Calling on the UK CBD sector to have better regulation and reform – Health Europa

Centre for Medicinal Cannabis survey finds six million adults used CBD in UK – NHS Executive

CBD oil brands contain little to no CBD, test by Sativa’s UK lab reveals – Proactive Investors

It is true that there are some rogue businesses and fake products but the impression given by this report is false, misleading and wildly inaccurate.  For nearly three years the leading CBD businesses in the UK have been engaged in serious, responsible self-regulation and consumers can be confident if they buy from members of the two trade associations Cannabis Professionals (CannaPro) or Cannabis Trades Association (CTA) they will be getting a quality product which is lab tested and contains exactly what is claimed.

The report is nothing but a market manipulation exercise by the authors. To understand why, it’s necessary to understand who is behind the ‘Centre for Medicinal Cannabis’ and examine their record.

The CMC is the latest front for Paul Birch, a multimillionaire, who since 2015 has been funding a series of ventures in the cannabis campaign. Mr Birch has brought one extremely valuable commodity to the campaign which it had been sorely lacking – money.  He has hired a lot of people with the right connections, impressive letters after their name and has thrown a great deal of his cash into expensive PR which, to be fair, has proved very effective. In fact, as with this CBD report, it is characterised by just how much media coverage it has obtained.  This, of course, has earned Birch’s cannabis ventures a reputation as leaders in their field. In fact, they are very much followers.  The content of their work is either directly copied from others’ work or is just a repeat of what has been done before.

The most high profile success achieved with Birch’s money and PR was the campaign around Billy Caldwell and Alfie Dingley, two children with severe epilepsy, whose stories touched the heart of the nation and under enormous moral pressure forced the UK government into long-overdue reform of its blanket ban on cannabis as medicine.  Birch’s money certainly made all the difference. Exactly the same stories and messages had been delivered to the media many times before but it is a fact of life that you only get on to the breakfast and daytime TV shows and in all the tabloids with a very expensive PR operation.

So Birch is at it again with the CMC. It describes itself as the UK’s first and only industry membership body for businesses and investors operating in cannabis based medicinal products (CBMPs) and cannabidiol (CBD) wellness markets.“, which is as wholly false a claim as has ever been published about anything, anywhere.

The existing trade associations, CannaPro and the CTA, were formed years before the CMC and between them represent nearly 1,000 businesses operating in the legal cannabis sector.  Neither of them were consulted before or since the CMC’s report and the fact of their existence and the work they do in regulating the industry has been excluded from the report.

Of course, the CMC won’t name the products which its report showed to be so deficient because this would show that they are not from members of CannaPro or CTA and are therefore not at all representative of what consumers are actually buying. The irony is that PhytoVista, the lab used by the CMC, is itself a member of the CTA and provides testing services to many CannaPro and CTA members.

So take the results of the CMC CBD report with a very large pinch of salt, or perhaps with a tablespoon of hempseed oil containing only a trace of CBD.  It doesn’t tell the truth. It paints a false picture of an industry that is actually a model of self-regulation.

Written by Peter Reynolds

July 9, 2019 at 3:38 pm

Review. ‘Cannabis Health’ Magazine

leave a comment »

This is a milestone in cannabis law reform.  A glossy magazine, produced to the highest standard, fit to sit alongside Country Life, Cosmopolitan or Vogue.  It treats the subject with intelligence, with insight and the stories it tells are told with respect, sensitivity and common sense.

It would be easy to have made this sensationalist, to have made exaggerated claims, launched strident attacks on those who still oppose consumption of the plant or fallen into the trap of folklore rather than science, magic rather than medicine.  The publishers have hit the bullseye with the right tone and style and provided it reaches the right coffee tables, perhaps doctors waiting rooms, it will help to drive reform. Never before have I been moved by a magazine but this represents the achievement of a level of acceptance that sometimes I doubted I would see in my lifetime.

CLEAR was able to contribute to this first issue, introducing our members, Robert Cohen and Marie Emma Smith, whose stories of how cannabis has transformed their lives are beautifully told and I am honoured to have been interviewed as part of a feature on the campaign.

It’s intended to be quarterly but I won’t be surprised if it takes off and becomes monthly before very long.  There is a huge reservoir of advertising expenditure which has been stymied by the short-sighted attitude of social media companies. It will be poetic justice if traditional publishing can do well out of the reintroduction of this traditional medicine. A free, one year, postal subscription is available to the first 10,000 people to register by emailing chloe@aspectpublishing.co.uk

There is still a logjam of prejudice and lack of understanding, particularly amongst cowardly politicians and a medical establishment that feels threatened by a subject where patients know more than doctors.  ‘Cannabis Health’ wll help to break this down.  The sheer weight of public support, enthusiasm and real life experience will soon leave these sceptics desperate to catch up.  Get yourself a copy and enjoy quality writing about cannabis published in print rather than online.  The world is changing!

Written by Peter Reynolds

June 6, 2019 at 3:31 pm

The CBD Market Can Help Drive Cannabis Law Reform But Selling So-Called ‘CBD Flowers’ Could Take Us Backwards

leave a comment »

Jim Weathers of Puff ‘n Stuff CBD shop, Cork, Ireland

Compliant businesses operating responsibly within the legal cannabis sector will help to drive reform. Blurring the lines between legal and illegal products will delay progress.

It seems that the crackdown on the open sale of cannabis flowers online and in high street stores is here.  Both in the UK and Ireland, several shops have been raided in recent weeks and some people are facing potential charges of supplying a class B drug and a possible jail sentence.

These flowers, sold under meaningless pseudonyms such as ‘CBD buds’ or ‘hemp flowers’ are cannabis and cannabis is a controlled drug in both the UK and Ireland.  As CLEAR has been warning for many months, there is no way that these can ever be ‘exempt products’ in the same way as CBD oil.  Their THC content makes no difference. The penalty is the same for any type of cannabis whether it contains zero THC or 25% THC.

It’s unclear whether CBD oil is legal at all in Ireland.  A more accurate description for these products is low-THC cannabis extracts and whereas the UK makes specific provision for exempt products in the Misuse of Drugs Regulations 2001, there does not seem to be any such provision in Irish law.

In other EU countries an even wider crackdown on CBD products is underway, fuelled also by the extraordinary and clearly unsustainable attempt to deem all cannabis extracts as ‘novel foods’.

Now it shouldn’t need to be said but CLEAR stands for an end to the prohibition of cannabis and all our work is directed towards that end.  Some people seem very confused that our efforts to clarify the law mean that we are on the side of prohibition but this is not the case.  Through our trade association, Cannabis Professionals (CannaPro) we refuse to certify businesses that sell cannabis flowers.  They are cheating their customers by misleading them that these products are legal.  They are also cheating all those other businesses operating within the legal cannabis sector who are working hard to remain compliant.  They are undermining the very good work that the CBD industry is doing to drive wider cannabis law reform.

Of course, many of us are buying cannabis illegally already.  Without our local dealers where would we all be under the oppressive and ridiculous regime under which we live? But our aim and the aim of all responsible cannabis campaigns is to ‘get the dealers off the street’ and move the trade into licensed, regulated outlets.  The emergence of the CBD market and high street retailers selling CBD oil has shown how this could work and there is no doubt at all that it has been a very significant factor in increasing public acceptance of cannabis and the recent reforms for medical access.

The people selling cannabis flowers and claiming they are legal are not heroes, campaigners or warriors in the war on prohibition. They are confidence tricksters, seizing the opportunity to make a quick buck by cheating and endangering their customers. No one is going to go to jail for buying cannabis but if you’ve bought low THC flowers and get charged with possession that could ruin you future prospects of travel, a career, even of keeping your driving licence.  If you’re going to take that risk you need to do so with your eyes open, with the honest trade of an illegal dealer rather than the dishonest trade of a shop or a website that is telling you lies.

Also, be very careful what you are buying.  The ‘CBD flowers’ currently being advertised are most certainly not what they claim to be.  The strain names are being misused.  White Widow, Lemon Haze or Pineapple Express do not come with 20% CBD and only traces of THC.  These products have been doctored.  There simply aren’t any cannabis strains that contain these constituents in these proportions.  What is probably happening is that they are being sprayed with CBD isolate and possibly terpene extracts to come with what are artificial cannabis buds.  Buy these and you are being cheated on many levels and you really don’t know what you are actually inhaling.

We are making steady and accelerating progress towards a rational cannabis policy but this latest development is unwelcome and unhelpful.  Trust your usual dealer.  If you’re buying cannabis flower, it comes with THC.  If you want added CBD take a little oil or vape some CBD crumble.  This will give you a far better result than these fake flowers. It will enhance the therapeutic properties of your cannabis if you’re consuming for medical reasons.  It will give you a far better buzz if you’re consuming for pleasure.

Nothing good will come from these fake flowers. Compliant businesses operating responsibly within the legal cannabis sector will help to drive reform. Blurring the lines between legal and illegal products will delay progress.

 

 

Written by Peter Reynolds

May 21, 2019 at 2:40 pm

The EU’s Attempt To Deem Cannabis Extracts As Novel Foods Will Fail.

with one comment

Status of Hemp Extracts in Europe – European Industrial Hemp Association

The European Industrial Hemp Association (EIHA) has published an excellent eight page document which refutes the recent move by EU food safety agencies to deem cannabis extracts as ‘novel foods’.

Download the document here.

The document explains the entire situation and demonstrates very clearly that this move by the EU is misguided. It shows how these products have been consumed in Europe fro many years, if not centuries, probably millennia and that the EU has previously confirmed in writing that they are not novel.

Aside from these fundamental issues, there are a number of reasons why the process the EU and the UK Food Standards Agency (FSA) have followed is flawed and unlawful.

What seems absolutely clear is that this initiative, which is intended to close down the burgeoning CBD market, is based on the intervention of vested interests which are concerned to see a multimillion pound/euro industry emerge in the space of a few years, almost exclusively amongst small and medium-sized businesses.  This is an opportunity which multinational conglomerates have missed and there is no doubt that its success is affecting many existing markets, notably over-the-counter pain medicines.

The EU and government agencies such as the FSA have always been the friends of big business and the intention here has been to force small business into huge costs associated with novel food authorisation which would effectively close their businesses down.

There are many overblown conspiracy theories, particularly around cannabis for medical use and the pharmaceutical industry but this attack on the CBD market, for no valid reason, is difficult to explain in any other way. It seems certain that improper pressure has been brought to bear on these regulators and they are trying to use their powers, improperly and unlawfully, to protect the interests of big business.

They are too late.  The CBD business has grown very quickly and is now too far advanced to be closed down and there is no justifiable reason to do so.  This attempt to impose novel foods status will fail.

 

Written by Peter Reynolds

May 13, 2019 at 10:20 am

CBD Switzerland. Whole Plant Extract From Swiss-Grown Industrial Hemp.

leave a comment »

Although something in my value system, no doubt instilled in my now very distant childhood, tells me that medicine is supposed to taste bad, there is no strict correlation between nasty taste and powerful effect.  Some cannabis extracts taste foul, others are bearable and there a few that capture the distinctive, earthy taste of the plant and are really very nice.

The first time I saw a bottle of CBD Switzerland oil, I was pretty sceptical.  It’s virtually crystal clear and I thought this is isolate in a carrier oil or it’s had all the goodness refined out of it – but the taste is just wonderful. The new trend for cooking with cannabis is a strange mix of hype, ignorance, fad-of-the-moment veganism and in a few cases its about getting high but there is a cannabis taste that is really desirable and works well in both sweet and savoury dishes.  CBD Switzerland has captured that taste in a bottle.

The lab tests and a week of regular use confirmed for me that this is very much the real thing.  There are other oils that I also rate very highly for taste but the combination of taste and clarity is stunning and I expect it is what more and more consumers will be looking for as the CBD market matures.  This is probably the most modern, consumer friendly oil on the market. No doubt, a little further down the line, the same expertise in extraction and refinement can be applied to a THC product and that will be a winner.

CBD Switzerland offers its oil in virtually any specification required, either zero THC or with the trace levels that are present in a full spectrum extract from plants with 0.2% THC.  Standard concentrations are 5%, 10%, 15%, 20% or 25% in either hempseed or MCT carrier oil.  Full spectrum soft gels are available containing 10mg CBD each.  Recently a THC-free distillate has been added with either 95% or 75% CBD content, a full spectrum, liposomal, water soluble mix and CBD vape liquid.  As a white label supplier, CBD Switzerland offers everything that a CBD business could need to formulate and produce its own products.

Download the CBD Switzerland brochure here.

Written by Peter Reynolds

April 25, 2019 at 3:42 pm

CannaPro Seizes the Initiative in the CBD and Novel Foods Debacle

with 2 comments

Cannabis Professionals (CannaPro), the trade association for the UK’s cannabis, CBD and hemp businesses, has instructed solicitors to take decisive action in the ongoing row between the Food Standards Agency (FSA) and the UK’s fastest-growing food supplement market for cannabidiol (CBD) products.

TLT Solicitors, acting on behalf of CannaPro, has sent a formal letter to the FSA warning it of the consequences of taking any enforcement action against CannaPro Certified Businesses.  An industry-wide claim for such compensation could amount to many hundreds of millions of pounds/euros.  A copy of the letter can be seen here. This offers some degree of protection to all businesses that are CannaPro Certified.

Acting in conjunction with its opposite numbers in several EU states, the FSA has sought to classify CBD products and all cannabis extracts as ‘novel’ by listing them in the EU Novel Food catalogue. This threatens to destroy a market that is now worth up to £100 million pa, employs hundreds of people and is meeting the healthcare and wellness needs of hundreds of thousands of UK citizens.

A ‘novel food’ is defined as a food or food ingredient that was not in widespread consumption in the EU area before 1997.  In reality, cannabis, in varieties known as hemp, has been consumed as food for at least 10,000 years and is listed in the Guinness Book of Records as the world’s oldest cultivated crop. The FSA’s action is irrational, defies history and reverses previous statements by the FSA that cannabis and hemp are not ‘novel’.

Peter Reynolds, president of CannaPro, said:

“The FSA has made a series of errors in the way it has handled this.  The whole process has been misguided and unlawful, not to say that the whole idea CBD products can be regarded as novel is nonsense. It has undertaken no proper consultation and although there have been vague discussions around the issue for a couple of years, the FSA has changed its position time and time again.  What’s really going on here is that big business and powerful vested interests have been caught on the hop while enterprising small businesses have established a market which is now worth an awful lot of money. Improper pressure has been brought on the regulator to find a way of clamping down.  It would suit these vested interests to see the market so strictly regulated that small businesses are unable to compete.  CannaPro is not going to stand by and let that happen.”

Written by Peter Reynolds

March 26, 2019 at 6:00 pm